60-day uptake ‘quite modest’: expert

Pharmacy financials looking “pretty strong” due to low uptake of 60-day dispensing to date, says leading analyst, with first additional payments due by end of Oct Lower-than-expected uptake of 60-day scripts means additional funding announced in June to offset the measure should see pharmacies more than compensated for any losses, according to pharmacy business consultant